dc.creatorBeltrame, Sabrina Paola
dc.creatorCarrera Paez, Laura Camila
dc.creatorAuger, Sergio Ricardo
dc.creatorSabra, Ahmad H.
dc.creatorBilder, Claudio Rubén
dc.creatorWaldner, Claudia Ines
dc.creatorGoin, Juan Carlos
dc.date.accessioned2021-09-17T11:49:06Z
dc.date.accessioned2022-10-15T00:06:15Z
dc.date.available2021-09-17T11:49:06Z
dc.date.available2022-10-15T00:06:15Z
dc.date.created2021-09-17T11:49:06Z
dc.date.issued2020-03
dc.identifierBeltrame, Sabrina Paola; Carrera Paez, Laura Camila; Auger, Sergio Ricardo; Sabra, Ahmad H.; Bilder, Claudio Rubén; et al.; Impairment of agonist-induced M2 muscarinic receptor activation by autoantibodies from chagasic patients with cardiovascular dysautonomia; Academic Press Inc Elsevier Science; Clinical Immunology; 212; 3-2020; 1-9
dc.identifier1521-6616
dc.identifierhttp://hdl.handle.net/11336/140632
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4322824
dc.description.abstractPrevious studies showed that circulating autoantibodies against M2 muscarinic receptors (anti-M2R Ab) are associated with decreased cardiac parasympathetic modulation in patients with chronic Chagas disease (CD). Here we investigated whether the exposure of M2R to such antibodies could impair agonist-induced receptor activation, leading to the inhibition of associated signaling pathways. Preincubation of M2R-expressing HEK 293T cells with serum IgG fractions from chagasic patients with cardiovascular dysautonomia, followed by the addition of carbachol, resulted in the attenuation of agonist-induced Gi protein activation and arrestin-2 recruitment. These effects were not mimicked by the corresponding Fab fractions, suggesting that they occur through receptor crosslinking. IgG autoantibodies did not enhance M2R/arrestin interaction or promote M2R internalization, suggesting that their inhibitory effects are not likely a result of short-term receptor regulation. Rather, these immunoglobulins could function as negative allosteric modulators of acetylcholine-mediated responses, thereby contributing to the development of parasympathetic dysfunction in patients with CD.
dc.languageeng
dc.publisherAcademic Press Inc Elsevier Science
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://linkinghub.elsevier.com/retrieve/pii/S1521661619304991
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.clim.2020.108346
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectMUSCARINIC RECEPTORS
dc.subjectAUTOANTIBODIES
dc.subjectCHAGAS
dc.subjectDYSAUTONOMIA
dc.titleImpairment of agonist-induced M2 muscarinic receptor activation by autoantibodies from chagasic patients with cardiovascular dysautonomia
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución